AMF-26

N/A

Report date: 2024/10/16 17:38:13
NME

Base Information

Drug NameAMF-26
Drug Alias Name2-methylcoprophilinamideM-COPA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionADP Ribosylation Factor 1 inhibitors
TargetsADP Ribosylation Factor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A